Literature DB >> 10738300

Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.

J A Biegel1, B Fogelgren, L M Wainwright, J Y Zhou, H Bevan, L B Rorke.   

Abstract

We describe a four-month-old child who presented with an atypical teratoid/rhabdoid tumor of the brain and subsequently developed a renal rhabdoid tumor. Distinct histologic features, immunophenotypic profiles, and deletions of chromosome 22 were supportive of two primary tumors. An identical mutation in exon 7 of the INI1 rhabdoid tumor suppressor gene was identified in both tumors, as well as in normal kidney tissue. We propose that this germline INI1 mutation predisposed the child to the development of both malignancies. These findings lend support to the hypothesis that rhabdoid tumors in all sites have a common genetic etiology. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738300     DOI: 10.1002/(sici)1098-2264(200005)28:1<31::aid-gcc4>3.0.co;2-y

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  31 in total

1.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice.

Authors:  C W Roberts; S A Galusha; M E McMenamin; C D Fletcher; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

3.  Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.

Authors:  Michael S Isakoff; Courtney G Sansam; Pablo Tamayo; Aravind Subramanian; Julia A Evans; Christine M Fillmore; Xi Wang; Jaclyn A Biegel; Scott L Pomeroy; Jill P Mesirov; Charles W M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

4.  Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes.

Authors:  S P Meyers; Z P Khademian; J A Biegel; S H Chuang; D N Korones; R A Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

Review 5.  Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification.

Authors:  Ian F Pollack; Jaclyn Biegel; Allan Yates; Ronald Hamilton; Sydney Finkelstein
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

6.  Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.

Authors:  Emilia M Pinto; Dima Hamideh; Armita Bahrami; Brent A Orr; Tong Lin; Stanley Pounds; Gerard P Zambetti; Alberto S Pappo; Amar Gajjar; Sameer Agnihotri; Alberto Broniscer
Journal:  Acta Neuropathol       Date:  2018-02-10       Impact factor: 17.088

7.  SWI/SNF complex-deficient soft tissue neoplasms: An update.

Authors:  Inga-Marie Schaefer; Jason L Hornick
Journal:  Semin Diagn Pathol       Date:  2020-06-05       Impact factor: 3.464

Review 8.  A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature.

Authors:  Mariela C Coccé; Fabiana Lubieniecki; Uwe Kordes; Daniel Alderete; Marta S Gallego
Journal:  J Neurooncol       Date:  2010-12-03       Impact factor: 4.130

9.  Rapid detection of SMARCB1 sequence variation using high resolution melting.

Authors:  Vinod Dagar; Chung-Wo Chow; David M Ashley; Elizabeth M Algar
Journal:  BMC Cancer       Date:  2009-12-13       Impact factor: 4.430

10.  Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.

Authors:  Hironori Fujisawa; Yasushi Takabatake; Toshio Fukusato; Osamu Tachibana; Yoshitake Tsuchiya; Junkoh Yamashita
Journal:  J Neurooncol       Date:  2003-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.